Kwame was only 29 when he was told he needed spinal surgery. Years of back pain had worsened into something unbearable—his movements were limited, his job was at risk, and the prospect of paralysis ...

My fiance and I plan to have kids someday. I was wondering if it would be beneficial to keep our babies’ umbilical cords, ...

In a groundbreaking medical advancement, scientists have initiated the first human trial of spermatogonial stem cell (SSC) ...

A new study in the peer-reviewed journal Stem Cells and Development highlights the potential of mesenchymal stem cell (MSC)-derived extracellular vesicles (EVs) as a therapeutic strategy for high-dose ...

Three home runs. One saved life. Pacific Lutheran University's Carson Burke redefined what it means to be a hero on and off the diamond in under 72 hours. The junior delivered game-changing hits to ...

A new study in the peer-reviewed journal Stem Cells and Development highlights the potential of mesenchymal stem cell (MSC)-derived extracellular vesicles (EVs) as a therapeutic strategy for high-dose ...

Marshall University is no stranger to giving back to the community, but on April 8 and 9, students and staff had the ...

Jeff Auletta, MD, discussed the ACCESS trial and explained that mismatched unrelated donor transplants can be a viable option ...

Researchers are studying why the energy factories are moving between cells and whether the process can be harnessed to treat ...

"It's way more important than anything I do on the field. I love what I do on the field, but, I mean, this is what it's ...

Drug-carrying DNA aptamers can deliver a one-two punch to leukemia by precisely targeting the elusive cancer stem cells that seed cancer relapses, researchers at the University of Illinois ...

Drug-carrying DNA aptamers can deliver a one-two punch to leukemia by precisely targeting the elusive cancer stem cells that seed cancer relapses, researchers report. The aptamers -- short ...